Niraparib FDA approval date

The FDA approved Niraparib (Zejula) on 27 Mar 2017.

FDA approval date
27 Mar 2017

Drug identity checked against registry records

Also recorded as Zejula

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-03-27DayNiraparibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208447", "applicant_as_listed_by_fda": "GLAXOSMITHKLINE", "brand_names": ["ZEJULA"], "active_ingredients": ["NIRAPARIB TOSYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170327", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026